Ahmet Fuat
Overview
Explore the profile of Ahmet Fuat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crundall A, Crawshaw-Ralli M, Fuat A, Oberoi K, Crossan J, Jones S, et al.
Br J Cardiol
. 2025 Feb;
31(3):037.
PMID: 39917566
Heart failure (HF) is a prevalent and complex condition that demands precise and efficient management. This paper delves into a critical, yet often under-recognised, challenge in HF care - the...
2.
Loke I, Antoniou S, Boramakot R, Walters D, Fuat A
Br J Gen Pract
. 2024 Sep;
74(740):103-105.
PMID: 39222434
No abstract available.
3.
Bahar J, Rahman A, Wong G, Sankaranarayanan R, Ahmed F, Taylor R, et al.
ESC Heart Fail
. 2024 Jul;
PMID: 39013806
Patients with acutely decompensated heart failure (ADHF) are usually admitted to hospital for management. There is growing interest in delivering intravenous (IV) diuretic therapy at home, in the community or...
4.
Cuthbert J, Soyiri I, Lomax S, Turgoose J, Fuat A, Cohen J, et al.
Heart
. 2024 Apr;
110(12):854-862.
PMID: 38631899
Background: Loop diuretics are commonly prescribed in the community, not always to patients with a recorded diagnosis of heart failure (HF). The rate of HF events in patients prescribed loop...
5.
Nakao Y, Nadarajah R, Shuweihdi F, Nakao K, Fuat A, Moore J, et al.
BMJ Open
. 2024 Jan;
14(1):e073455.
PMID: 38253453
Introduction: Heart failure (HF) is increasingly common and associated with excess morbidity, mortality, and healthcare costs. Treatment of HF can alter the disease trajectory and reduce clinical events in HF....
6.
Fuat A, Adlen E, Monane M, Coll R, Groves S, Little E, et al.
Eur J Prev Cardiol
. 2024 Jan;
31(6):716-722.
PMID: 38243727
Aims: The aim of the study was to assess the real-world feasibility, acceptability, and impact of an integrated risk tool for cardiovascular disease (CVD IRT, combining the standard QRISK®2 risk...
7.
Fuat A, Ako E, Hargroves D, Holden D, Caleyachetty A, Carter M, et al.
J Mark Access Health Policy
. 2023 Nov;
11(1):2267327.
PMID: 37954532
Objective: Direct oral anticoagulants (DOACs) are first-line therapy for stroke prevention for 1.4 million atrial fibrillation (AF) patients in the UK. However, the rates of DOAC dosing below evidence-based recommendations...
8.
Gallagher H, Dumbleton J, Maishman T, Whitehead A, Moore M, Fuat A, et al.
Trials
. 2022 Apr;
23(1):331.
PMID: 35449015
Background: Chronic kidney disease (CKD) is a very common long-term condition and powerful risk factor for cardiovascular disease (CVD). Low-dose aspirin is of proven benefit in the secondary prevention of...
9.
Charman S, Okwose N, Taylor C, Bailey K, Fuat A, Ristic A, et al.
Fam Pract
. 2022 Jan;
39(5):805-812.
PMID: 35083480
Background: Diagnostic tools available to support general practitioners diagnose heart failure (HF) are limited. Objectives: (i) Determine the feasibility of the novel cardiac output response to stress (CORS) test in...
10.
Briggs A, Howarth A, Davies S, Schneider J, Spentzouris G, Mughal F, et al.
J Comp Eff Res
. 2022 Jan;
PMID: 35068197
No abstract available.